Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$17.60 -0.62 (-3.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Return on Equity [ROE] (2016 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Return on Equity [ROE] of -625.06% in Q2 2026, down 456.85 percentage points from -168.21% a year earlier and down 240.26 percentage points from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Return on Equity [ROE] (2016 - 2026) Analysis & Trends

For FY2025, Syndax Pharmaceuticals reported Return on Equity [ROE] of -141.95%, down 67.49 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for four straight years, with a five-year change of -90.54 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -74.46% in FY2024 (-33.54 pp), -40.91% in FY2023 (-6.88 pp), -34.03% in FY2022 (-41.52 pp) and 7.49% in FY2021 (+58.89 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q2 2016.
  • On a year-over-year basis, Return on Equity [ROE] has declined for 15 consecutive quarters, with an average year-over-year change of -162.39 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 46.11 percentage points in Q4 2021, against a drop of 456.85 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -384.79% (Q1 2026), -278.09% (Q4 2025) and -206.17% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Syndax Pharmaceuticals 1.57 Bn -160.92 Mn 69.58 Mn -625.06%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -625.06%
Mar 31, 2026 -384.79%
Dec 31, 2025 -278.09%
Sep 30, 2025 -206.17%
Jun 30, 2025 -168.21%
Mar 31, 2025 -126.33%
Dec 31, 2024 -95.81%
Sep 30, 2024 -74.15%
Jun 30, 2024 -56.96%
Mar 31, 2024 -45.95%
Dec 31, 2023 -45.76%
Sep 30, 2023 -46.28%
Jun 30, 2023 -38.23%
Mar 31, 2023 -33.83%
Dec 31, 2022 -37.00%
Sep 30, 2022 -4.02%
Jun 30, 2022 0.11%
Mar 31, 2022 3.86%
Dec 31, 2021 8.14%
Sep 30, 2021 -44.26%
API Access

Syndax Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SNDX&period=max&api_key=YOUR_API_KEY